New hope for women with Tough-to-Treat cervical cancer
Disease control
Not yet recruiting
This study is testing whether a new drug combination (WX390 plus toripalimab) works better than standard treatments for women with advanced cervical cancer that has returned or spread after previous platinum-based therapy. The trial will involve 440 participants across multiple c…
Phase: PHASE3 • Sponsor: Shanghai Jiatan Pharmatech Co., Ltd • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC